Agentic AI in Health: From Decentralized Data Ledgers to Lab-in-the-Loop Discovery
The RoX Health team is inviting you in Zürich for an interactive, high-signal evening exploring how agentic AI and frontier models are reshaping both ends of the healthcare value chain—from lab-in-the-loop drug discovery to health data analytics and research.
Expect live interaction, technical debates, and hands-on workflow breakdowns alongside fellow builders in the space!
What We Will Cover
Next-Gen Health Data Management & Research: Advances in sequencing and sensing technology, individual data management using the Ark I health data ledger, and tailored analytical and research workflows that go beyond generalist models.
Autonomous Drug Discovery: AI applications spanning the drug discovery pipeline, featuring end-to-end automated lab experimentation and lab-in-the-loop workflows.
Community Apéro: Informal networking over drinks and snacks to connect with the local healthtech ecosystem.
Speakers & Hosts
Mathieu Chaffard – RoX Health
Martin Karlsson – coordination.network
Rafael Rolli – Molecule
Péter Szilágyi – Dark.Bio
Who Should Apply & Curation Process
We are looking for Zürich-based (and nearby) computer science professionals, healthtech entrepreneurs, phyisicians or researchers currently working in—or adjacent to—AI-based drug discovery, computational biology, RWD, or health data analytics.
Pre-registration is open to everyone, but spots are limited. To ensure a highly relevant and participatory atmosphere, invitations will be confirmed individually following profile review.
---
RoX Health operates at the intersection of startups, healthcare systems and the Roche Group. Our role is to connect emerging innovation with Roche's global capabilities and translate promising ideas into scalable healthcare solutions.
Working with startups, innovators and healthcare partners, we create environments where new digital health concepts can be tested, validated and prepared for scale.
Through access to expertise, networks and industry insight, we support partners along the journey from early validation to scalable innovation.